888-776-0942 from 8 AM - 10 PM ET
DUBLIN , Sept. 21, 2022 /PRNewswire/ -- The "Medical Devices: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.
This report incorporates an in-depth analysis of the medical device technolog
© 2022 WWB Holdings, LLC. All rights reserved
A cochlear implant consists of a microphone and speech processor that sit outside the body and a receiver/stimulator that is placed under skin and muscle behind the ear.
WEST CHESTER, Pa., Sept. 21, 2022 /PRNewswire/ — Centinel Spine®, LLC, a leading global medical device company addressing cervical and lumbar spinal disease through anterior surgical access, today announced the first implantation of its prodisc® C Vivo Cervical Total Disc Replacem
Permanent link to this press release:
Delete press release Edit press rele
DUBLIN--(BUSINESS WIRE )--The "Spinal Cord Stimulators (SCS) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" report has been added to ResearchAndMarkets.com's offering.
The publisher's Medical Devices sec
Hi, what are you looking for?
Data Bridge Market Research analyzes that the market is growing with a CAGR of 11.3% in the forecast period of 2022 to 2029 and is expected to reach USD 3,402.90 million by 2029.
To achieve business growth and achievements in this rapidly changing mar
The DEXA SOLO-L ALIF device allows doctors to match the implant to patients' bone density and quality.
The US Food and Drug Administration (FDA) has granted 510K clearance for Aurora Spine’s DEXA SOLO-L anterior lumbar interbody fusion device (ALIF).
Please enter a work/business
Zimmer Biomet's latest device clearance and five more updates from spine and orthopedic devicemakers since Sept. 14:
1. Stryker launched its Pulse Intelligent Delivery Platform, which is designed to improve foot and ankle procedures performed at ASCs by monitoring and replenishing produc
A new implantable shock absorber can help to relieve pain and improve function in patients with chronic knee pain, according to results from a clinical trial performed by David Flanigan, MD, professor of orthopedics at Ohio State College of Medicine.
Dr. Flanigan enrolled patients